<unk>  is a combination of carbonic anhydrase inhibitor and beta-adrenergic blocker that is FDA approved for the {{{indicationType}}} of open-angle glaucoma or ocular hypertension.   Common adverse reactions include hypertension, taste sense altered, dizziness, headache, tremor, blepharitis, blurred vision, burning sensation in eye, conjunctival hyperemia, excessive tear production, itching of eye, pain in eye, punctate keratitis, bronchitis, nasal congestion, upper respiratory infection.
Dorzolamide and Timolol Ophthalmic
Cetirizine ophthalmic solution 
Orbital cellulitis CT
Ophthalmoscope
Desmopressin acetate nasal spray
Brimonidine tartrate and Timolol maleate
Corneal transplantation
Ocular prosthesis